학술논문
Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP
Document Type
Article
Author
Driessen, J.; Kersten, M.J.; Tonino, S.H.; Liu, R.D.K.; Visser, L.; van den Berg, A.; Diepstra, A.; Zijlstra, J.M.; Lugtenburg, P.J.; Morschhauser, F.; Hutchings, M.; Amorim, S.; Gastinne, T.; Nijland, M.; Plattel, W.J.; Zwezerijnen, G.J.C.; Boellaard, R.; de Vet, H.C.W.; Arens, A.I.J.; Valkema, R.; Drees, E.E.E.; de Jong, D.
Source
In: Leukemia . (Leukemia, December 2022, 36(12):2853-2862)
Subject
Language
English
ISSN
14765551
08876924
08876924